• News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • CEO Statement
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
  • Investors
    • Overview
    • Rights Issue / Företrädesemission 2022
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Company Presesentation
    • The Share
      • Share Information
      • Largest Shareholders
      • Share Capital Development
      • Rights Issues / Företrädesemissioner
      • Previous Share Issuances
      • Analyst Coverage
    • Financial Reports
      • English
      • Swedish
    • Financial Calendar
    • Corporate governance
      • General Meetings
      • Nomination Committee / Valberedning
      • Auditor
      • Articles of Association
      • Board of Directors
      • Management
    • Certified Adviser
    • IR Contact
  • Career
  • Contact
logo
  • News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • CEO Statement
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
  • Investors
    • Overview
    • Rights Issue / Företrädesemission 2022
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Company Presesentation
    • The Share
      • Share Information
      • Largest Shareholders
      • Share Capital Development
      • Rights Issues / Företrädesemissioner
      • Previous Share Issuances
      • Analyst Coverage
    • Financial Reports
      • English
      • Swedish
    • Financial Calendar
    • Corporate governance
      • General Meetings
      • Nomination Committee / Valberedning
      • Auditor
      • Articles of Association
      • Board of Directors
      • Management
    • Certified Adviser
    • IR Contact
  • Career
  • Contact
Home / General Meetings
  • Overview
  • Rights Issue / Företrädesemission 2022
  • Press Releases
    • English
    • Swedish
    • Subscribe
  • Presentations
  • Company Presentation
  • The Share
    • Share Information
    • Largest Shareholders
    • Share Capital Development
    • Rights Issues / Företrädesemissioner
    • Analyst Coverage
  • Financial Reports
    • English
    • Swedish
  • Financial Calendar
  • Corporate Governance
    • General Meetings
    • Nomination Committee / Valberedning
    • Previous Nomination Committees
    • Auditor
    • Articles of Association
    • Board of Directors
    • Management
  • Certified Adviser
  • IR Contact

General Meetings

Annual General Meeting, 18th of May 2022

  • Minutes of Meeting AGM (Protokoll årsstämma), in Swedish
  • Press release, bulletin from AGM (in English)
  • Pressmeddelande från årsstämma (in Swedish)
  • Notice of AGM (in English)
  • Notice of AGM (in Swedish)
  • Proxy form for AGM (in English)
  • Proxy form for AGM (in Swedish)
  • Punkt 14 a) i). Styrelsens förslag till ny bolagsordning
  • Punkt 14 a) ii). Styrelsens förslag till ny bolagsordning
  • Punkt 14b. Styrelsens beslut om företrädesemission
  • Punkt 14b Bilaga A, fullständiga villkor teckningsoption TO3
  • Punkt 15. Beslut om riktad nyemission av aktier (Sv)
  • Item 15. Resolution on directed issue of shares (Eng)
  • Styrelsens redogörelse över väsentliga händelser
  • Revisorns yttrande enligt 13.16 och 14.8 perioden 2022-04-13 –2022-04-13
  • Styrelsens redogörelse enligt 13-7
  • Revisorns yttrande enligt 13 kap 7 § ABL
  • CEO Presentation

Annual General Meeting, 18th of May 2021

  • Minutes from the AG (in Swedish)
  • Notice of AGM (in English)
  • Notice of AGM (in Swedish)
  • Registration to attend AGM, and form for postal voting (in Swedish)
  • Proxy form for AGM (in Swedish)

Annual General Meeting, 14th of May 2020

  • Notice of AGM (in English) 
  • Notice of AGM (in Swedish) 
  • Terms for Subscription Warrants in favour of Board of Directors (in Swedish) 
  • Terms for Subscription Warrants in favour of key personnel (in Swedish) 
  • Proposal for long term incentive program in favour of Board of Directors (in Swedish) 
  • Proposal for long term incentive program in favour of key personnel (in Swedish)
  • Minutes from the AGM (in Swedish)

Extraordinary General Meeting, 27th of February 2020

  • Press release, notice of EGM
  • Press release, report from the EGM
  • Minutes from the EGM
  • Proposal new director of the board

Annual General Meeting, 16th of May 2019

  • Press release, report from the AGM
  • Press release, notice of AGM
  • Minutes from the AGM
  • Proposal amended articles of association

Extraordinary General Meeting, 26th of March 2019

  • Press release, report from the EGM
  • Press release, notice of AGM
  • Minutes from the EGM
  • Amended articles of association

Extraordinary General Meeting, 9th of November 2018

  • Press release, report from the EGM
  • Press release, notice of EGM
  • Minutes from the EGM
  • Authorisation preferential rights issue
  • Authorisation directed rights issue

Annual General Meeting, 17th of May 2018

  • Press release, report from the AGM
  • Press release, notice of AGM
  • Minutes from the AGM
  • Register of votes
  • Amended articles of association

Annual General Meeting, 17th of May 2017

  • Press release, report from the AGM
  • Press release, notice of AGM
  • Minutes from the AGM
  • Register of votes
  • Amended articles of association

 

 

Annual General Meeting, 18th of May 2016

  • Press release, report from the AGM
  • Press release, notice of AGM
  • Minutes from the AGM
  • Register of votes
  • Amended articles of association
  • News
  • Our Company
  • Patients & Families
  • R & D
  • Investors
  • Contact

Alzinova AB. Pepparedsleden 1, SE-431 83, Mölndal, Sweden
+46 (0) 708 467 975   info@alzinova.com

Follow us on

follow us on linkedin